David A. DeGoey
AbbVie (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, Computational Drug Discovery Methods, HIV Research and Treatment, Chemical Synthesis and Analysis
Most-Cited Works
- → Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection(2017)366 cited
- → In Vitro and In Vivo Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A(2014)130 cited
- → Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A(2014)126 cited
- → Peptidomimetic Inhibitors of HIV Protease(2004)99 cited
- → Antiviral Drug Discovery for the Treatment of COVID-19 Infections(2022)97 cited
- → Enantioselective Synthesis of Antiinfluenza Compound A-315675(2002)95 cited
- → Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape(2024)65 cited
- → Implications of the Conformationally Flexible, Macrocyclic Structure of the First-Generation, Direct-Acting Anti-Viral Paritaprevir on Its Solid Form Complexity and Chameleonic Behavior(2021)51 cited
- → Discovery of pyrido[2,3-d]pyrimidine-based inhibitors of HCV NS5A(2013)51 cited
- → Water-Soluble Prodrugs of the Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir(2009)37 cited